
Consolidated cash and cash equivalents as of September 30, 2022, were $33.1 million.
Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year. Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16. Consolidated cash and cash equivalents […]
“Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year. Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16. Consolidated cash and cash equivalents […]
· November 8, 2022
Crawford & Company (NYSE: CRD-A) reported revenues before reimbursements of $294.9 million for the third quarter of 2022, up 2% year-over-year.
Net loss attributable to shareholders was $15.1 million, or $0.31 per share, compared to net income of $11.2 million, or $0.20 per share, last year. Adjusted EPS was $0.16.

Consolidated cash and cash equivalents as of September 30, 2022, were $33.1 million.